When considering only biopsies performed after 2015, after introduction of the revised WHO classification [20], IDH was obtained in 96.9% (94/97) and MGMT in 92.8% (64/69) of high-grade glioma cases. The gene discussed is MGMT; the disease is central nervous system cancer.